Likewise, there are conflicting results or contradictory data about whether MBL2 genotypes or MBL deficiency could be used as mortality predictors in HSCT patients [13, 16, 17, 30, 31]. This evidence concerns the gene MBL2 and mannose-binding lectin deficiency.